After completing the Texas Biodesign program our team began pursuing development of the Infection Detective. By the summer of 2021 we had taken an important step in bringing our technolgy forward, incorporating as a Delaware C Corp.

We were selected as an E-team in the prestigious Venturewell E-team program at the Pioneer, and Propel levels. We participated in their workshops where we received coaching, mentorship, and conducted a series of customer discovery interviews that helped us adapt and improve on our value propositions, and our market strategies.

The team, led by Dr. Miles Massidda, Dr. Cristina Checka, and students participating in Texas Venture Labs Practicum have completed 140 customer discovery interviews to date. These interviews were conducted, in part, through business mentorship programs (VentureWell and Washington University’s Equalize). The interviews have targeted doctors, nurses, patients, and clinical purchasing teams to validate the clinical need for the device, mitigate regulatory hurdles, and identify viable sales channels. Additionally, preliminary interviews have been conducted to explore alternative verticals and use cases for our technology.